Stockreport

Vir Biotechnology Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF US$1.56 loss per share (further deteriorated from US$1.22 loss in 3Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue [Read more]